The FDA has given approval to Nexstim (Helsinki, Finland) to market the firm’s Navigated Brain Stimulation System for the “assessment of the primary motor cortex for pre-procedural planning”. The system uses traditional MRI data to guide the TMS (Transcranial Brain Stimulation) device to map the motor cortex so as to avoid performing direct cortical stimulation during brain surgery.
Integrated, TMS-compatible 6-channel EMG Designed for clinical use: Fast setup, ready to use in few minutes – complete documentation with online and offline reporting Accurate targeting of stimulation: Online calculation and display of location and strength of the stimulating intracranial electric field Guided and controlled repetition of any previous excitatory or inhibitory stimulus within 2 mm accuracy and 2 degrees tilting and orientation Repeatable sessions: Automatic recording of stimulation and response data, documentation of session workflow for later replication and analysis
Easy to use:
Software help tools available on-screen:
– Grid for systematic brain mapping
– Targeting tool for optimal coil placement
– Aiming tool for precise repetition of given stimuli
– Automated stimulation (location controlled)
– Display of somatotopic maps in colorOptimal performance with Nexstim eXimia TMS
Also programmable for compatibility with Medtronic/Magventure or Magstim TMS stimulators and coils
Press release: FDA clears Nexstim’s Navigated Brain Stimulation for non-invasive cortical mapping prior to neurosurgery…
Product page: eXimia NBS System with integrated EMG…
